Trials / Unknown
UnknownNCT05108077
Treatment of Metastatic Tumors of the Urogenital Area With Cytokine-induced Killer Cells
Treatment of Metastatic Tumors of the Urogenital Area (Bladder Cancer, Renal Cancel) With Cytokine-induced Killer Cells
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus · Other Government
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Treatment of metastatic tumors of the urogenital area with cytokine-induced killer cells
Detailed description
Treatment of metastatic tumors of the urogenital area using autologous cytokine-induced killer cells
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | cytokine-induced killer cells | Autologous cytokine-induced killer cells injected intravenously |
| OTHER | Standard treatment according to the Clinical protocols | Standard treatment of bladder/renal cancer according to the Clinical protocols |
Timeline
- Start date
- 2022-03-01
- Primary completion
- 2023-12-31
- Completion
- 2023-12-31
- First posted
- 2021-11-04
- Last updated
- 2022-01-14
Locations
1 site across 1 country: Belarus
Source: ClinicalTrials.gov record NCT05108077. Inclusion in this directory is not an endorsement.